文献速递胃肠外科围术期管理与 ERAS

内镜袖状胃成形术与腹腔镜袖状胃切除术安全性相当吗?倾向性匹配分析

Is endoscopic sleeve gastroplasty as safe as laparoscopic sleeve gastrectomy? A propensity-matched analysis.
PubMed 文献 · Surg Endosc · 2025-10-03

基于MBSAQIP数据库2020-2023年的回顾性分析,比较初次内镜袖状胃成形术(ESG)与腹腔镜袖状胃切除术(LSG)的30天术后结局。经1:4倾向性匹配后,ESG组主要并发症发生率(2.1% vs 1.4%,p=0.019)、再入院率(3.0% vs 1.7%,p=0.001)和干预率(0.7% vs 0.26%,p=0.003)均显著高于LSG组。ESG患者中,年龄(OR: 1.03; 95%CI: 1.00-1.06; p=0.022)和心血管疾病(OR: 6.95; 95%CI: 2.47-19.61; p<0.001)与主要并发症风险增加相关。

要点

  • ESG的30天主要并发症、再入院和干预率均高于LSG。
  • ESG患者年龄和心血管疾病是主要并发症的独立危险因素。
  • ESG需谨慎选择患者,尤其老年和心血管疾病者。

核心结论

  • ESG与LSG的30天总体不良事件率均较低,但ESG的主要并发症、再入院和干预率更高。
  • ESG患者需谨慎选择,尤其老年和心血管疾病患者。

研究设计与样本

  • 回顾性分析MBSAQIP数据库(2020-2023年),比较初次ESG与LSG手术。
  • 对16个基线变量进行1:4倾向性匹配,匹配后ESG组2171例,LSG组7997例。
  • 主要并发症定义为再次手术、再干预、非计划ICU入住、插管或严重器官功能障碍。

主要发现

  • 匹配后ESG组手术时间更长(81.3 vs 56.1分钟,p<0.001),住院时间更短(0.2 vs 1.2天,p<0.001)。
  • ESG组30天再入院率3.0% vs 1.7%(p=0.001),干预率0.7% vs 0.26%(p=0.003)。
  • ESG组主要并发症发生率2.1% vs 1.4%(p=0.019)。
  • ESG患者中,年龄(OR: 1.03; 95%CI: 1.00-1.06; p=0.022)和心血管疾病(OR: 6.95; 95%CI: 2.47-19.61; p<0.001)与主要并发症风险增加相关。

关键数值与推荐

  • 主要并发症定义包括再次手术、再干预、非计划ICU入住、插管或严重器官功能障碍。
  • LASSO回归识别出年龄、心血管疾病、COPD、睡眠呼吸暂停和治疗性抗凝五个变量,仅年龄和心血管疾病与主要并发症风险独立相关。

临床怎么用

  • ESG应视为一种替代选择,但需告知患者其主要并发症和再入院风险高于LSG。
  • 对老年和心血管疾病患者实施ESG前应仔细评估风险获益。

局限性

  • 回顾性数据库研究,可能存在未测量混杂。
  • ESG样本量相对较小(匹配后2171例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Endoscopic sleeve gastroplasty (ESG) reduces gastric volume via endoscopic suturing, offering a less invasive alternative to laparoscopic sleeve gastrectomy (LSG). However, their comparative safety remains inadequately explored. This study evaluates 30-day postoperative outcomes between ESG and LSG using a national database. METHODS: A retrospective analysis of the MBSAQIP database (2020-2023) was conducted comparing primary ESG and LSG procedures. Propensity score matching (1:4) was performed for 16 baseline variables, including demographics, BMI, ASA class, and comorbidities. Major complications were defined as significant postoperative adverse events, including reoperation, reintervention, unplanned ICU admission, intubation, or severe organ dysfunction. Outcomes were analyzed using t-test/rank-sum and Chi-square/Fisher's exact tests. Risk factors for major complications in ESG patients were identified using LASSO regression and multivariate logistic regression. RESULTS: Among 207,984 patients, 1% underwent ESG and 99% LSG. ESG patients were older (45.0 vs. 41.8 years, p < 0.001), predominantly female (86% vs. 81%, p < 0.001), and had lower BMI (39.9 vs. 45.0 kg/m2, p < 0.001). After matching (ESG: 2171; LSG: 7997), ESG was associated with longer operative times (81.3 vs. 56.1 min, p < 0.001), shorter hospital stays (0.2 vs. 1.2 days, p < 0.001), and higher 30-day readmission (3.0% vs. 1.7%, p = 0.001) and intervention rates (0.7% vs. 0.26%, p = 0.003). ESG had a significantly higher rate of major complications compared to LSG (2.1% vs. 1.4%, p = 0.019). Among five variables identified by LASSO (age, cardiovascular disease, COPD, sleep apnea, and therapeutic anticoagulation), only age (OR: 1.03; 95% CI: 1.00-1.06; p = 0.022) and cardiovascular disease (OR: 6.95; 95% CI: 2.47-19.61; p < 0.001) were associated with an increased risk of major complications in ESG patients. CONCLUSION: While both procedures showed low overall 30-day adverse event rates, ESG was associated with a higher rate of major complications, readmissions, and interventions. Careful patient selection for ESG is warranted, particularly for older patients and those with cardiovascular disease.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ebadinejad A, Saeidishahri S, Wu Y, et al. Is endoscopic sleeve gastroplasty as safe as laparoscopic sleeve gastrectomy? A propensity-matched analysis. Surg Endosc. 2025. PMID: 41042346. doi:10.1007/s00464-025-12165-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。